Medlere is a UK-based in vitro diagnostics (IVD) company focused on delivering innovative, high-performance diagnostic solutions for global healthcare systems.

We specialize in the development and manufacturing of a broad portfolio of clinical diagnostic platforms, including:

- Immunofluorescence (FiCA Series) analyzers – enabling multi-parameter immune and endocrine testing with high accuracy and efficiency
- POCT Chemiluminescence (UClia) systems – designed for rapid, sensitive, and flexible point-of-care testing
- Hematology analyzers (i-Hema series) – delivering stable, reliable CBC testing for clinical laboratories
- HPLC HbA1c systems (M3 platform) – providing gold-standard diabetes monitoring with high precision and strong method correlation
- Specialty diagnostic kits, including infectious disease and veterinary testing solutions

Our solutions are designed to support laboratories of all sizes—from reference labs to decentralized testing sites—by combining analytical performance, workflow efficiency, and cost-effectiveness.

At Medlere, we are committed to advancing diagnostic standards through continuous innovation, robust quality systems, and user-centered design. Our mission is to make high-quality diagnostics more accessible, reliable, and globally scalable.

With an expanding international footprint, Medlere partners with distributors and healthcare providers worldwide to improve diagnostic capacity and support better clinical decisions.

Medlere Limited

Org chart

Teams

Offices